Goldman Sachs says this little-known health stock can withstand volatile macro environment, rise more than 35%
This health testing name may be insulated from President Donald Trump's tariff uncertainty, according to Goldman Sachs.
You are not logged in so some information on this page has been withheld. To see more, please log in.